Literature DB >> 15009221

Evidence for linkage between juvenile myoclonic epilepsy-related idiopathic generalized epilepsy and 6p11-12 in Dutch families.

Dalila Pinto1, Gerrit-Jan de Haan, Guus A M A J Janssen, Eduard H Boezeman, M Gerard van Erp, Birgit Westland, Jorine Witte, Adri Bader, Dicky J J Halley, Dorothée G A Kasteleijn-Nolst Trenité, Dick Lindhout, Bobby P C Koeleman.   

Abstract

PURPOSE: Previous linkage studies provided evidence for juvenile myoclonic epilepsy (JME) susceptibility loci at 6p11-12, HLA-6p21.3 region, 15q14, and 5q34. These results indicate locus heterogeneity or interpopulation differences, thus underlining the importance of replication studies.
METHODS: We describe a replication linkage study of the 6p-q13 region in 18 families ascertained from JME probands of Dutch descent. In the presence of heterogeneity, the definition of the disease status may be crucial, and we therefore used two disease phenotypes: narrow [JME/idiopathic generalized epilepsy (IGE)-"only"] and broad (JME/IGE-plus-fast EEG background activity).
RESULTS: We found evidence of linkage at 6p11-12 in multipoint analyses (p < 0.01 in a replication study) for both these disease definitions. Analysis of this region, assuming heterogeneity and autosomal dominant inheritance with a conservative 60% of penetrance, gave a maximum multipoint parametric lod score of 2.07 at D6S1573 for the narrow phenotype and peaked at 2.53 between D6S1623 and D6S1573 for the broad phenotype. The p value for nonparametric linkage reached 0.0013 for the narrow phenotype and 0.0010 for the broad. Significant exclusion (lod score <or=2) was found for the HLA region and for 10 to 30 cM telomeric to HLA. Our results provide evidence for a susceptibility locus for JME/IGE-plus-fast EEG background activity at 6p11-12.
CONCLUSIONS: Additionally, by using a narrow definition, we were able to confirm previous evidence for a JME-IGE locus at this location.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15009221     DOI: 10.1111/j.0013-9580.2004.36003.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  6 in total

1.  The path to open-angle glaucoma gene discovery: endophenotypic status of intraocular pressure, cup-to-disc ratio, and central corneal thickness.

Authors:  Jac Charlesworth; Patricia L Kramer; Tom Dyer; Victor Diego; John R Samples; Jamie E Craig; David A Mackey; Alex W Hewitt; John Blangero; Mary K Wirtz
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-03-17       Impact factor: 4.799

Review 2.  The state of the art in the genetic analysis of the epilepsies.

Authors:  David A Greenberg; Deb K Pal
Journal:  Curr Neurol Neurosci Rep       Date:  2007-07       Impact factor: 5.081

3.  DNA variants in coding region of EFHC1: SNPs do not associate with juvenile myoclonic epilepsy.

Authors:  Dongsheng Bai; Julia N Bailey; Reyna M Durón; María E Alonso; Marco T Medina; Iris E Martínez-Juárez; Toshimitsu Suzuki; Jesús Machado-Salas; Ricardo Ramos-Ramírez; Miyabi Tanaka; Ramón H Castro Ortega; Minerva López-Ruiz; Astrid Rasmussen; Adriana Ochoa; Aurelio Jara-Prado; Kazuhiro Yamakawa; Antonio V Delgado-Escueta
Journal:  Epilepsia       Date:  2009-05       Impact factor: 5.864

Review 4.  Evaluating candidate genes in common epilepsies and the nature of evidence.

Authors:  Deb K Pal; Lisa J Strug; David A Greenberg
Journal:  Epilepsia       Date:  2007-11-19       Impact factor: 5.864

5.  Phenotypic concordance in 70 families with IGE-implications for genetic studies of epilepsy.

Authors:  Peter Kinirons; Daniel Rabinowitz; Micheline Gravel; James Long; Melodie Winawer; Geneviève Sénéchal; Ruth Ottman; Patrick Cossette
Journal:  Epilepsy Res       Date:  2008-08-23       Impact factor: 3.045

6.  Pathogenic EFHC1 mutations are tolerated in healthy individuals dependent on reported ancestry.

Authors:  Ryan L Subaran; Juliette M Conte; William C L Stewart; David A Greenberg
Journal:  Epilepsia       Date:  2014-12-08       Impact factor: 5.864

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.